Publications by authors named "Roberta Grande"

Claim this Profile
E
Efficacy of third-line anti-EGFR-based treatment versus regorafenib or trifluridine/tipiracil according to primary tumor site in RAS/BRAF wild-type metastatic colorectal cancer patients.
Lisa Salvatore, Maria Bensi, Raffaella Vivolo, Ina Valeria Zurlo, Emanuela Dell'Aquila, Roberta Grande

Front Oncol· February 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Regorafenib-to-trifluridine/tipiracil Versus the Reverse Sequence for Refractory Metastatic Colorectal Cancer Patients: A Multicenter Retrospective Real-life Experience.
Carlo Signorelli, Donatello Gemma, Roberta Grande, Salvatore DE Marco, Rosa Saltarelli

Anticancer Res· May 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Oligometastatic colorectal cancer: prognosis, role of locoregional treatments and impact of first-line chemotherapy-a pooled analysis of TRIBE and TRIBE2 studies by Gruppo Oncologico del Nord Ovest.
Roberto Moretto, Daniele Rossini, Gemma Zucchelli, Sara Lonardi, Francesca Bergamo, Roberta Grande

Eur J Cancer· November 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Upfront FOLFOXIRI plus bevacizumab and reintroduction after progression versus mFOLFOX6 plus bevacizumab followed by FOLFIRI plus bevacizumab in the treatment of patients with metastatic colorectal cancer (TRIBE2): a multicentre, open-label, phase 3, randomised, controlled trial.
Chiara Cremolini, Carlotta Antoniotti, Daniele Rossini, Sara Lonardi, Fotios Loupakis, Roberta Grande

Lancet Oncol· April 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Activity and Safety of Cetuximab Plus Modified FOLFOXIRI Followed by Maintenance With Cetuximab or Bevacizumab for RAS and BRAF Wild-type Metastatic Colorectal Cancer: A Randomized Phase 2 Clinical Trial.
Chiara Cremolini, Carlotta Antoniotti, Sara Lonardi, Giuseppe Aprile, Francesca Bergamo, Roberta Grande

JAMA Oncol· April 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Treatment of Metastatic Colorectal Cancer Patients ≥75 Years Old in Clinical Practice: A Multicenter Analysis.
Roberta Grande, Clara Natoli, Fabrizio Ciancola, Donatello Gemma, Arianna Pellegrino

PLoS One· July 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evaluation of relapse-free survival in T3N0 colon cancer: the role of chemotherapy, a multicentric retrospective analysis.
Roberta Grande, Domenico Corsi, Raffaello Mancini, Donatello Gemma, Fabrizio Ciancola

PLoS One· March 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Changing monoclonal antibody keeping unaltered the chemotherapy regimen in metastatic colorectal cancer patients: is efficacy maintained?
Roberta Grande, Donatello Gemma, Isabella Sperduti, Alain Gelibter, Maria Anna Giampaolo

Springerplus· December 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Maintenance single-agent bevacizumab or observation after first-line chemotherapy in patients with metastatic colorectal cancer: a multicenter retrospective study.
Luca Moscetti, Fabrizio Nelli, Maria A Fabbri, Isabella Sperduti, Daniele Alesini, Roberta Grande

Invest New Drugs· August 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pre-emptive skin toxicity treatment for anti-EGFR drugs: evaluation of efficacy of skin moisturizers and lymecycline. A phase II study.
Roberta Grande, Filomena Narducci, Sara Bianchetti, Giovanni Mansueto, Donatello Gemma

Support Care Cancer· June 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Symptom improvement as prognostic factor for survival in cancer patients undergoing palliative care: a pilot study.
Filomena Narducci, Roberta Grande, Lucia Mentuccia, Tiziana Trapasso, Isabella Sperduti

Support Care Cancer· June 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Palonosetron plus 3-day aprepitant and dexamethasone to prevent nausea and vomiting in patients receiving highly emetogenic chemotherapy.
Flavia Longo, Giovanni Mansueto, Vittoria Lapadula, Rita De Sanctis, Silvia Quadrini, Roberta Grande

Support Care Cancer· August 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Adjuvant chemotherapy in esophageal cancer.
Vincenzo Picone, Giuliana D'Auria, Roberta Ferraldeschi, Roberta Grande, Virginia Passeri

Rays· December 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis